Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Magnuson

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Circulation|June 4, 2024
Projections of Soaring Costs Are A Call to ArmsElizabeth A Magnuson
Circulation|June 4, 2019
Added Sugar LabelingElizabeth A Magnuson, Paul S Chan
Heart (British Cardiac Society)|June 29, 2012
Understanding the cost-effectiveness of bivalirudinAmit P Amin, Elizabeth A Magnuson
Nature Reviews. Cardiology|August 10, 2011
Cost-effectiveness of oral antiplatelet agents--current and future perspectivesSuzanne V Arnold, David J Cohen, Elizabeth A Magnuson
Vascular Medicine (London, England)|October 4, 2021
Catheter-directed thrombolysis for deep vein thrombosis: 2021 updateSamuel Z Goldhaber, Elizabeth A Magnuson, Khaja M Chinnakondepalli, et al.
JAMA|October 17, 2013
Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trialMouin S Abdallah, Kaijun Wang, Elizabeth A Magnuson, et al.
Circulation. Cardiovascular Quality and Outcomes|April 13, 2012
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisonsSuzanne V Arnold, Elizabeth A Magnuson, Kaijun Wang, et al.
Journal of the American Heart Association|September 2, 2017
Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 TrialKaijun Wang, Haiyan Li, Winghan J Kwong, et al.
Circulation. Cardiovascular Interventions|July 21, 2022
Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL TrialElizabeth A Magnuson, Khaja Chinnakondepalli, Katherine Vilain, et al.
Circulation. Cardiovascular Quality and Outcomes|October 13, 2011
Survival benefit with drug-eluting stents in observational studies: fact or artifact?Lakshmi Venkitachalam, Yang Lei, Elizabeth A Magnuson, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Circulation|June 4, 2024
Projections of Soaring Costs Are A Call to ArmsElizabeth A Magnuson
Circulation|June 4, 2019
Added Sugar LabelingElizabeth A Magnuson, Paul S Chan
Heart (British Cardiac Society)|June 29, 2012
Understanding the cost-effectiveness of bivalirudinAmit P Amin, Elizabeth A Magnuson
Nature Reviews. Cardiology|August 10, 2011
Cost-effectiveness of oral antiplatelet agents--current and future perspectivesSuzanne V Arnold, David J Cohen, Elizabeth A Magnuson
Vascular Medicine (London, England)|October 4, 2021
Catheter-directed thrombolysis for deep vein thrombosis: 2021 updateSamuel Z Goldhaber, Elizabeth A Magnuson, Khaja M Chinnakondepalli, et al.
JAMA|October 17, 2013
Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trialMouin S Abdallah, Kaijun Wang, Elizabeth A Magnuson, et al.
Circulation. Cardiovascular Quality and Outcomes|April 13, 2012
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisonsSuzanne V Arnold, Elizabeth A Magnuson, Kaijun Wang, et al.
Journal of the American Heart Association|September 2, 2017
Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 TrialKaijun Wang, Haiyan Li, Winghan J Kwong, et al.
Circulation. Cardiovascular Interventions|July 21, 2022
Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL TrialElizabeth A Magnuson, Khaja Chinnakondepalli, Katherine Vilain, et al.
Circulation. Cardiovascular Quality and Outcomes|October 13, 2011
Survival benefit with drug-eluting stents in observational studies: fact or artifact?Lakshmi Venkitachalam, Yang Lei, Elizabeth A Magnuson, et al.
Pageof 7